Trachoma is a cause of blindness that has long been neglected. We were therefore delighted to see material on the diagnosis of trachoma in a recent issue of Annals of Emergency Medicine.1 However, we think the case that prompted the submission of this paper is more likely to be allergic rather than infectious in origin, for two reasons. First, the reported tearing and itch that are prominent in the history would be atypical for trachoma,2 but are classic features of an allergic conjunctivitis. Second, the papillary hypertrophy noted by the authors in their description and clearly displayed on their excellent photograph is caused by giant papillae rather than the lymphoid follicles of trachoma. These two entities may provoke diagnostic uncertainty; both can cause conjunctival elevation, but giant papillae are relatively translucent, > 1mm in diameter, and tend to be quite protuberant above the plane of the conjunctival surface, while follicles are grey-white, creamy or yellow-coloured, can be as small as 0.5mm in diameter and still be considered significant,3 and lie deep to conjunctival epithelial cells: the surface of the epithelium can be elevated as a consequence of their presence, but not to the extent of the cobblestoning sometimes seen with giant papillae. For the purposes of standardizing population-based surveys to estimate the prevalence of trachoma, intensive training courses are conducted for ophthalmic health workers.4, 5 For emergency room work, however, reference to the grading card of the WHO simplified system3 may be helpful.
Footnotes
Conflicts of interest: None
Disclaimer: MISD is a staff member of the Pan American Health Organization (PAHO); AWS is a staff member of the World Health Organization (WHO). The authors alone are responsible for the views expressed in this publication, and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated. In any reproduction of this article, there should be no suggestion that PAHO, WHO, or this article endorse any specific organization, products, or services. The use of the PAHO or WHO logos is not permitted. This notice should be preserved along with the article’s original URL.
Contributor Information
Sandra L. Talero, School of Ophthalmology, Barraquer Institute, Bogota, Colombia.
Serge Resnikoff, the Organisation pour la Prévention de la Cécité, Paris, France.
Martha Idalí Saboyá-Díaz, the Pan-American Health Organization, Washington DC, USA.
Anthony W. Solomon, the World Health Organization, Geneva, Switzerland.
References
- 1.de Oliveira Alves A, Ferreira VS, Bernardes Filho F. Young Boy With Roughening in the Inner Eyelids. Ann Emerg Med. 2018;71(3):e13–e4. doi: 10.1016/j.annemergmed.2017.10.008. [DOI] [PubMed] [Google Scholar]
- 2.Solomon AW, Peeling RW, Foster A, Mabey DC. Diagnosis and assessment of trachoma. Clin Microbiol Rev. 2004;17(4):982–1011. doi: 10.1128/CMR.17.4.982-1011.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477–83. [PMC free article] [PubMed] [Google Scholar]
- 4.Solomon AW, Pavluck A, Courtright P, Aboe A, Adamu L, Alemayehu W, et al. The Global Trachoma Mapping Project: methodology of a 34-country population-based study. Ophthalmic Epidemiol. 2015;22(3):214–25. doi: 10.3109/09286586.2015.1037401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Solomon AW, Willis R, Pavluck AL, Alemayehu W, Bakhtiari A, Bovill S, et al. Quality Assurance and Quality Control in the Global Trachoma Mapping Project. Am J Trop Med Hyg. 2018;99(4):858–63. doi: 10.4269/ajtmh.18-0082. [DOI] [PMC free article] [PubMed] [Google Scholar]